Recap: Reata Pharmaceuticals Q1 Earnings

Comments
Loading...

Reata Pharmaceuticals RETA reported its Q1 earnings results on Wednesday, May 10, 2023 at 06:40 AM.

Here's what investors need to know about the announcement.

Earnings

Reata Pharmaceuticals beat estimated earnings by 25.21%, reporting an EPS of $-1.81 versus an estimate of $-2.42.

Revenue was down $719 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.12 which was followed by a 11.77% drop in the share price the next day.

Here's a look at Reata Pharmaceuticals's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -2.21 -2.18 -2.02 -2.15
EPS Actual -2.33 -1.47 -1.36 -1.33
Revenue Estimate 430K 640K 1.46M 1.55M
Revenue Actual 0 540K 762K 914K

To track all earnings releases for Reata Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!